USP4 and hepatocellular carcinoma: Of the newly identified two targets of miR-148a (i.e., USP4 and S1P1), USP4 overexpression contributed to HCC progression toward more aggressive feature by facilitating TGF-β signaling pathways, growth advantage and migrating capability.